Posted on 6/26/18
electroCore Announces Closing of IPO
BASKING RIDGE, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq:ECOR) today announced the closing of its initial public offering of 5,200,000 shares of common stock . . .
Posted on 6/26/18
Ebb Therapeutics Wins Silver at the Prestigious MDEA Awards
Earlier this month, medtech start-up Ebb Therapeuticswas recognized with a Silver Medal at the Medical Design Excellence Awards (MDEA). The company was the only manufacturer honored . . .
Posted on 7/13/18
Interview with Scott Applebaum, President of Context Therapeutics - Part III
Brought to you by Newmark Knight Frank
Posted on 7/10/18
Interview with Scott Applebaum, President of Context Therapeutics - Part II
Brought to you by Newmark Knight Frank
Posted on 6/29/18
Interview with Scott Applebaum, President of Context Therapeutics - Part I
Brought to you by Newmark Knight Frank
Posted on 6/26/18
Johnson & Johnson Offers A Favorable Price For Long-Term Investors
Since peaking in early January, Johnson & Johnson (JNJ) has declined about 18% and now offers long-term investors an opportunity to buy a wide moat, blue-chip, . . .
Posted on 6/26/18
Is PTC Therapeutics Stock a Buy?
PTC Therapeutics (NASDAQ:PTCT) shares went on a roller-coaster ride after the drugmaker unveiled important data -- and so did a competitor. The company is making progress . . .
Posted on 6/25/18
Agadia Systems Announces Agreement with MaxorPlus
Agadia Systems, Inc. (Agadia), an innovator in electronic prior authorization and MTM solutions, and MaxorPlus, a full service PBM pioneering the use of mobile technology to . . .
Posted on 6/25/18
Health Plus Management Acquires AdvancedPMR
Health Plus Management, LLC (Health Plus) is pleased to announce the acquisition of Advanced PMR Management
Posted on 6/25/18
Johnson & Johnson Offers A Favorable Price For Long-Term Investors
Since peaking in early January, Johnson & Johnson (JNJ) has declined about 18% and now offers long-term investors an opportunity to buy a wide moat, blue-chip, . . .
Posted on 6/25/18
Immune Pharmaceuticals And Bertilimumab: A Work In Progress
Investment Analysis:Immune Pharmaceuticals (NASDAQ:IMNP) is a clinical stage biopharmaceutical company focused on the development and commercialization of its lead candidate Bertilimumab, for the treatment of Bullous . . .
Posted on 6/24/18
Joslin Diabetes Center, The American Journal of Managed Care® Collaborate to Publish Clinical Guidelines
CRANBURY, N.J. & BOSTON--(BUSINESS WIRE)--The American Journal of Managed Care®has published core clinical guidelines from Joslin Diabetes Center, the world-renowned center for research, treatment, and education . . .
Posted on 6/24/18
Matinas BioPharma Closes $8.0 Million Public Offering
BEDMINSTER, N.J., June 22, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines . . .
Posted on 6/22/18
electroCore Prices IPO
BASKING RIDGE, N.J., June 21, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) today announced the pricing of its initial public offering of 5,200,000 shares of common . . .
Posted on 6/22/18
AtlantiCare Extends Partnership with Continuum Health
AtlantiCare, a member of Geisinger, has extended its partnership with Continuum Health to provide revenue cycle services for AtlantiCare Physician Group's more than 96 primary and . . .
Posted on 6/21/18
MD Magazine Expands Strategic Alliance Partnership Program
CRANBURY, N.J.--(BUSINESS WIRE)--MD Magazine®, a leading online and print source of physician news, conference coverage and peer-to-peer discussion, adds NYU Langone Health to its Strategic Alliance . . .
Posted on 6/21/18
Marinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 Index
RADNOR, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Posted on 6/21/18
Johnson & Johnson: Strong Company, But Won't Fit In Most Portfolios
Johnson & Johnson (NYSE:JNJ) is a company with strong financial health and a lot of cash is currently being held for future acquisitions. JNJ is only . . .
Posted on 6/21/18
Buy Johnson & Johnson
Over the last number of months, bonds have been dropping and yields have been rising. As such, many of the more defensive stocks that trade along . . .
Posted on 6/21/18
Don't Get Too Excited About PTC Therapeutics (Yet)
PTC Therapeutics (NASDAQ:PTCT) shares took off after updated data from a trial evaluating risdiplam suggested it could mount a stiff challenge to Biogen's (NASDAQ:BIIB) and Ionis . . .
Posted on 6/21/18
Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks
If you own Johnson & Johnson (NYSE:JNJ) stock, there's a really good chance that you do so because of its dividend. The healthcare giant is a . . .
Posted on 6/21/18
ContraVir Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
EDISON, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the . . .
Posted on 6/20/18
Buy Johnson & Johnson
Over the last number of months, bonds have been dropping and yields have been rising. As such, many of the more defensive stocks that trade along . . .
Posted on 6/20/18
Better Buy: Celgene Corporation vs. Merck
A series of setbacks caused Celgene Corporation (NASDAQ:CELG) stock to tumble around 47% from a peak reached last October. Over the same time frame, Merck & . . .
Posted on 6/20/18
Children's Hospital of Philadelphia Announces New Hospital
Children's Hospital of Philadelphia (CHOP) today announced a major expansion plan off its main campus, calling for the construction of a new inpatient hospital in King . . .

